1 - 25 of 15
Number of results to display per page
TitleCreatorDate
1 75th Annual Meeting of the American Academy of NeurologyMeagan D. Seay; Kathleen B. Digre2023-09
2 Social Media in Neuro-Ophthalmology: Paradigms, Opportunities, and StrategiesKevin E. Lai; Aileen A. Antonio; Melissa W. Ko; Joel P. Epling; Anne X. Nguyen; Andrew R. Carey2023-09
3 15th European Neuro-Ophthalmology Society Meeting, Birmingham, England, June 20-23, 2022Kathleen B. Digre; Meagan D. Seay2022-12
4 Complications of Ventriculoperitoneal Shunt for Idiopathic Intracranial Hypertension: A Single-Institution Study of 32 PatientsAnthony J. Brune; Taania Girgla; Jonathan D. Trobe2021-06
5 A Zoom Conversation With Richard Sogg, MD, on the Occasion of His 90th Birthday, August 2020Jonathan D. Trobe2021-03
6 Temporal Artery Biopsy in the Workup of Giant Cell Arteritis: Diagnostic Considerations in a Veterans Administration CohortLaura D. Selby, BS; Brenna A. M. Park-Egan, BS; Kimberly M. Winges, MD2020-12
7 A Tribute to Dr. John R. GuyM. Tariq Bhatti, MD2020-12
8 The 2020 Update to North American Neuro-Ophthalmology Society's (NANOS) Neuro-Ophthalmology CurriculumSachin Kedar; Kathleen B. Digre; Valérie Biousse2020-09
9 Drs. Richard John Leigh and David ZeeMeagan D. Seay; Kathleen B. Digre; Janet C. Rucker2020-09
10 Great Conversations: Dr. Barrett KatzMeagan Seay; Elizabeth Fortin; Kathleen Digre2019-09
11 Vigabatrin: Lessons Learned From the United States ExperienceRod Foroozan, MD2018-12
12 A Profile of Neuro-Ophthalmic Practice Around the WorldLarry P. Frohman, MD2018-03
13 Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor UseAlbert S. Li, MD; Howard D. Pomeranz, MD, PhD2016-12
14 Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting SystemHoward D. Pomeranz, MD, PhD2016-06
15 Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular ManifestationsJason H. Peragallo, MD; Elena Bitrian, MD; Mark J. Kupersmith, MD; Fritz Zimprich, MD, PhD; Thomas J. Whittaker, MD, JD; Michael S. Lee, MD; Beau B. Bruce, MD, PhD2016-03
1 - 25 of 15